Adverse Drug Reactions (ADRs) represent a major burden to global healthcare systems and are largely responsible for the high attrition rate of potential new drugs within the pharmaceutical industry. The Centre for Drug Safety Science funded by the Medical Research Council was established in 2008 to create a world-class centre for the investigation of the fundamental mechanisms of clinically important ADRs, aided by close ties with the pharmaceutical industry and regulatory agencies.
We use cutting edge chemical, biochemical, cell biology, molecular and pharmacogenomic techniques to identify how certain drugs can cause ADRs and to predict which patients may be predisposed to drug-specific ADRs with the aim of informing safer drug design and improving the clinical use of individualized medicines.
The Centre is part of the internationally-recognized Department of Molecular and Clinical Pharmacology at the University of Liverpool, with world-leading experts in drug metabolism, immunopharmacology and personalized medicine.
The Centre funding has recently been renewed by the Medical Research Council for a further five year cycle, and as part of the renewal we have 5 prestigious PhD studentships on offer. Each studentship will fund home/EU fees (£3,996) and stipend (£13,863).
We are looking for outstanding applicants from the UK/EU who have obtained (or be about to obtain) at least an upper second class Honours degree (or equivalent) in a Life Sciences area. Applicants from outside of the EU may be considered, but would need to be able to supplement the tuition fees.
How to Apply
Formal applications should include a curriculum vitae with the names, address and telephone numbers of two referees, together with a personal statement that details why the applicant want to pursue a PhD at the Centre for Drug Safety Science, and the research areas that interest them. The closing date for applications is Monday 24 February. Applications should be sent to Karen Clayson. Short-listed applicants will be invited to interview on 5 March where they will be given an opportunity to tour the department and meet with academic leads and other students. We will work with successful applicants to define suitable projects.
Description: This flexible part-time online programme provides a knowledge and understanding of the key elements and principles of clinical trial design, delivery and analysis, in addition to the principles of GCP and their practical implementation in clinical trials. It is suitable for graduates in medicine, nursing, pharmacy, life sciences and other allied disciplines involved in Clinical Trials.
Dates: Next intake: September 2014. It takes 12 months to complete the Certificate, 24 months to complete the Diploma and 36 months to complete the Masters.
A suite of flexible postgraduate programmes and short courses designed specifically for physicians, pharmacists and scientists.